Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to look at how effective two drugs, nivolumab and
ipilimumab, are for people with non-small lung cancer that has metastasized (has spread to
other parts of the body) and to see what effects these drugs have on these tumors.